Nvidia’s CEO Jensen Huang announced groundbreaking developments in artificial intelligence (AI) technology during his presentation at the Computex tech expo in Taipei, Taiwan. Among the key highlights was the launch of Nvidia Isaac GR00T-Dreams, a framework designed to generate extensive synthetic motion data that AI developers can employ to enhance robotic behavior.
In addition, Nvidia introduced NVLink Fusion, a new solution allowing users to create custom server configurations incorporating Nvidia’s Grace CPU alongside a third-party AI chip. This continues Nvidia’s commitment to expanding its server infrastructure capabilities.
Despite a 2.5% dip in pre-market trading, Nvidia’s stock performance has shown resilience, with a notable 29% increase over the past month. Huang further discussed the company’s partnership with Saudi Arabian tech company Humain, where Nvidia will supply semiconductors for the enhancement of Humain’s data center operations.
In related market news, shares of Hong Kong-listed Alibaba fell 3% following reports of scrutiny from the U.S. government concerning a potential deal between Alibaba and Apple regarding the integration of AI technology on iPhones in China. This development added to pressure on Alibaba shares, which were already down due to disappointing earnings results that missed analyst expectations.
Meanwhile, in the biotech sector, Novavax saw a substantial 17% increase in its stock price after receiving conditional approval from the U.S. Food and Drug Administration (FDA) for its Covid-19 vaccine. The FDA approval is specifically for individuals aged 65 and older, as well as for those aged 12 and up with underlying health conditions that increase the risk of severe illness.
These advancements in technology and healthcare signal positive movement in sectors critical to both the economy and public health, reflecting ongoing innovation and adaptation in a rapidly changing landscape.